论文部分内容阅读
于1987年起,对54例肝硬变患者采用口服汉防己甲素50mg每日3次抗肝纤维化的治疗.分别于服药前及服药后6、12、18个月测定血清透明质酸(HA)、血清Ⅲ型前胶原肽(PⅢP)
In 1987, 54 patients with cirrhosis were treated with oral administration of tetrandrine 50mg three times a day for anti-hepatic fibrosis.Serum hyaluronic acid (HbA1c) was measured before treatment and at 6, 12 and 18 months HA), serum type procollagen peptide (PIIIP)